New research showed higher rates of STIs and STI recurrence in MSM using PrEP who reported engaging in sexualized drug use, ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...

Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has ...

Utilizing syringe service programs to provide comprehensive PrEP care shows promise for encouraging more people who inject ...

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...

Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.

Gilead (GILD) stock in focus as its HIV anti-viral lenacapavir shows promise in HIV prevention with once-yearly PrEP ...

Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...

Harbour BioMed created Élancé Therapeutics to develop bispecific antibody drugs for weight loss. Elsewhere, Geron’s CEO is ...

A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Before taking Descovy” section. Preexposure prophylaxis (PrEP) refers to taking ...